166 related articles for article (PubMed ID: 26563384)
1. Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals.
Yanik EL; Clarke CA; Snyder JJ; Pfeiffer RM; Engels EA
J Am Soc Nephrol; 2016 May; 27(5):1495-504. PubMed ID: 26563384
[TBL] [Abstract][Full Text] [Related]
2. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.
van Leeuwen MT; Webster AC; McCredie MR; Stewart JH; McDonald SP; Amin J; Kaldor JM; Chapman JR; Vajdic CM; Grulich AE
BMJ; 2010 Feb; 340():c570. PubMed ID: 20150194
[TBL] [Abstract][Full Text] [Related]
3. Cancer incidence among Canadian kidney transplant recipients.
Villeneuve PJ; Schaubel DE; Fenton SS; Shepherd FA; Jiang Y; Mao Y
Am J Transplant; 2007 Apr; 7(4):941-8. PubMed ID: 17331115
[TBL] [Abstract][Full Text] [Related]
4. De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data.
Park B; Yoon J; Choi D; Kim HJ; Jung YK; Kwon OJ; Lee KG
Sci Rep; 2019 Nov; 9(1):17202. PubMed ID: 31748582
[TBL] [Abstract][Full Text] [Related]
5. Cancer risks after solid organ transplantation and after long-term dialysis.
Hortlund M; Arroyo Mühr LS; Storm H; Engholm G; Dillner J; Bzhalava D
Int J Cancer; 2017 Mar; 140(5):1091-1101. PubMed ID: 27870055
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus use and cancer incidence among US kidney transplant recipients.
Yanik EL; Gustafson SK; Kasiske BL; Israni AK; Snyder JJ; Hess GP; Engels EA; Segev DL
Am J Transplant; 2015 Jan; 15(1):129-36. PubMed ID: 25522018
[TBL] [Abstract][Full Text] [Related]
7. Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants.
Sexton DJ; O'Kelly P; O'Leary E; Murray S; Deady S; Daly F; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Moloney FJ; O'Neill JP; Conlon PJ
JAMA Dermatol; 2019 May; 155(5):594-598. PubMed ID: 30725084
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study.
Hibberd AD; Trevillian PR; Wlodarczyk JH; Kemp DG; Stein AM; Gillies AH; Heer MK; Sheil AG
Transplantation; 2013 Jan; 95(1):122-7. PubMed ID: 23238532
[TBL] [Abstract][Full Text] [Related]
9. Polycystic kidney disease and cancer after renal transplantation.
Wetmore JB; Calvet JP; Yu AS; Lynch CF; Wang CJ; Kasiske BL; Engels EA
J Am Soc Nephrol; 2014 Oct; 25(10):2335-41. PubMed ID: 24854270
[TBL] [Abstract][Full Text] [Related]
10. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
12. Cancer incidence before and after kidney transplantation.
Vajdic CM; McDonald SP; McCredie MR; van Leeuwen MT; Stewart JH; Law M; Chapman JR; Webster AC; Kaldor JM; Grulich AE
JAMA; 2006 Dec; 296(23):2823-31. PubMed ID: 17179459
[TBL] [Abstract][Full Text] [Related]
13. Cancer survival in kidney transplant recipients in Ireland.
Murray SL; O'Leary E; De Bhailís ÁM; Deady S; Daly FE; O'Kelly P; Williams Y; O'Neill JP; Sexton DJ; Conlon PJ
Nephrol Dial Transplant; 2020 Oct; 35(10):1802-1810. PubMed ID: 32638007
[TBL] [Abstract][Full Text] [Related]
14. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression and other risk factors for lip cancer after kidney transplantation.
van Leeuwen MT; Grulich AE; McDonald SP; McCredie MR; Amin J; Stewart JH; Webster AC; Chapman JR; Vajdic CM
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):561-9. PubMed ID: 19190169
[TBL] [Abstract][Full Text] [Related]
16. The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis.
Ma MK; Lim WH; Turner RM; Chapman JR; Craig JC; Wong G
Transplantation; 2014 Dec; 98(12):1286-93. PubMed ID: 25119131
[TBL] [Abstract][Full Text] [Related]
17. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
[TBL] [Abstract][Full Text] [Related]
18. De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012.
Mazzucotelli V; Piselli P; Verdirosi D; Cimaglia C; Cancarini G; Serraino D; Sandrini S
J Nephrol; 2017 Dec; 30(6):851-857. PubMed ID: 28317077
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
Bhat M; Mara K; Dierkhising R; Watt KDS
Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
[TBL] [Abstract][Full Text] [Related]
20. Liver Transplant Recipients With End-Stage Renal Disease Largely Benefit From Kidney Transplantation.
Yunhua T; Qiang Z; Lipeng J; Shanzhou H; Zebin Z; Fei J; Zhiheng Z; Linhe W; Weiqiang J; Dongping W; Zhiyong G; Xiaoshun H
Transplant Proc; 2018; 50(1):202-210. PubMed ID: 29407310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
